Gemcitabine-induced severe pulmonary toxicity.
Barlési F, Villani P, Doddoli C, Gimenez C, Kleisbauer JP.
Barlési F, et al.
Fundam Clin Pharmacol. 2004 Feb;18(1):85-91. doi: 10.1046/j.0767-3981.2003.00206.x.
Fundam Clin Pharmacol. 2004.
PMID: 14748759
Review.
Activity of gemcitabine is demonstrated in the treatment of many solid tumors, like pancreas, ovarian and nonsmall cell lung cancer (NSCLC). Although gemcitabine is considered as a drug with a good safety profile, cases of gemcitabine-induced severe pulmonary toxicity (GIS …
Activity of gemcitabine is demonstrated in the treatment of many solid tumors, like pancreas, ovarian and nonsmall cell lung cancer ( …